Loading live market data…

EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

$13.73 USD

-$0.55 (-3.85%)

Volume
1.06M
Average Volume
1.15M
Market Capitalization
$1.15B
P/E Ratio
-3.92
Dividend Yield
0.00%
Price Target
$37.50
Year High
$19.11
Year Low
$9.40
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$6.66

EYPT Estimated and Actual Revenue by Quarter

EYPT Estimated and Actual EPS by Quarter

EYPT Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 -438.67K -438.67K -438.67K -438.67K -438.67K -438.67K
2027-09-30 3 -405.33K -405.33K -405.33K -405.33K -405.33K -405.33K
2027-06-30 3 -338.67K -338.67K -338.67K -338.67K -338.67K -338.67K
2027-03-31 4 -338.67K -338.67K -338.67K -338.67K -338.67K -338.67K
2026-12-31 4 -350.85K -350.85K -350.85K -350.85K -350.85K -350.85K
2026-09-30 7 -359.92K -359.92K -359.92K -359.92K -359.92K -359.92K
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 -60.49M -60.49M -60.49M 603.63K 603.63K 603.63K
2027-09-30 3 -63.64M -63.64M -63.64M 557.76K 557.76K 557.76K
2027-06-30 3 -67.94M -67.94M -67.94M 466.03K 466.03K 466.03K
2027-03-31 4 -63.35M -63.35M -63.35M 466.03K 466.03K 466.03K
2026-12-31 4 -70.37M -70.37M -70.37M 482.79K 482.79K 482.79K
2026-09-30 7 -86.8M -49.02M -70.46M 495.28K 495.28K 495.28K
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 438.67K 438.67K 438.67K 2 -0.70333 -0.70333 -0.70333
2027-09-30 3 405.33K 405.33K 405.33K 2 -0.74 -0.74 -0.74
2027-06-30 3 338.67K 338.67K 338.67K 2 -0.79 -0.79 -0.79
2027-03-31 4 338.67K 338.67K 338.67K 3 -0.73667 -0.73667 -0.73667
2026-12-31 4 350.85K 350.85K 350.85K 3 -0.8183 -0.8183 -0.8183
2026-09-30 7 359.92K 359.92K 359.92K 7 -1.00934 -0.56998 -0.81935